CLINICAL_TRIALS
trial_result
· 2018-02-20
Clinical Trial Update: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection [Phase 3]
Summary
Phase 3 trial update on sofobuvir plus ribavirin in adults with chronic hepatitis C shows efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Chronic HCV Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-02-20